As of 2024-12-11, the Relative Valuation of Exagen Inc (XGN) is (14.32) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.23 USD, the upside of Exagen Inc based on Relative Valuation is -438.6%.
The range of the Relative Valuation is (13.41) - (16.81) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.0x - 17.5x | 14.6x |
| Forward P/E multiples | 10.8x - 18.0x | 15.2x |
| Fair Price | (13.41) - (16.81) | (14.32) |
| Upside | -417.1% - -497.4% | -438.6% |
| Date | P/E |
| 2024-12-11 | -4.62 |
| 2024-12-10 | -4.41 |
| 2024-12-09 | -4.61 |
| 2024-12-06 | -4.74 |
| 2024-12-05 | -4.61 |
| 2024-12-04 | -4.68 |
| 2024-12-03 | -4.90 |
| 2024-12-02 | -4.37 |
| 2024-11-29 | -4.14 |
| 2024-11-27 | -4.00 |
| 2024-11-26 | -4.11 |
| 2024-11-25 | -4.22 |
| 2024-11-22 | -4.27 |
| 2024-11-21 | -4.09 |
| 2024-11-20 | -4.38 |
| 2024-11-19 | -3.68 |
| 2024-11-18 | -3.13 |
| 2024-11-15 | -3.11 |
| 2024-11-14 | -3.02 |
| 2024-11-13 | -2.87 |
| 2024-11-12 | -2.91 |
| 2024-11-11 | -3.10 |
| 2024-11-08 | -2.97 |
| 2024-11-07 | -2.71 |
| 2024-11-06 | -2.63 |
| 2024-11-05 | -2.56 |
| 2024-11-04 | -2.57 |
| 2024-11-01 | -2.68 |
| 2024-10-31 | -2.53 |
| 2024-10-30 | -2.62 |
| 2024-10-29 | -2.70 |
| 2024-10-28 | -2.72 |
| 2024-10-25 | -2.80 |
| 2024-10-24 | -2.96 |
| 2024-10-23 | -2.85 |
| 2024-10-22 | -2.95 |
| 2024-10-21 | -2.92 |
| 2024-10-18 | -3.00 |
| 2024-10-17 | -2.83 |
| 2024-10-16 | -2.93 |
| 2024-10-15 | -2.81 |
| 2024-10-14 | -2.81 |
| 2024-10-11 | -2.76 |
| 2024-10-10 | -2.81 |
| 2024-10-09 | -2.83 |
| 2024-10-08 | -2.87 |
| 2024-10-07 | -3.06 |
| 2024-10-04 | -3.13 |
| 2024-10-03 | -3.08 |
| 2024-10-02 | -2.99 |